Teleflex Incorporated (TFX)
| Previous Close | 200.45 |
| Open | 201.40 |
| Bid | 204.17 x 1200 |
| Ask | 204.33 x 800 |
| Day's Range | 199.76 - 204.48 |
| 52 Week Range | 177.63 - 262.97 |
| Volume | |
| Avg. Volume | 328,693 |
| Market Cap | 9.631B |
| Beta (5Y Monthly) | 1.12 |
| PE Ratio (TTM) | 32.72 |
| EPS (TTM) | 6.25 |
| Earnings Date | Aug 01, 2024 - Aug 05, 2024 |
| Forward Dividend & Yield | 1.36 (0.68%) |
| Ex-Dividend Date | May 14, 2024 |
| 1y Target Est | 246.92 |
GlobeNewswireTeleflex Expands Intraosseous Vascular Access Portfolio with New Arrow™ EZ-IO™ Intraosseous Access Procedure Tray
The First and Only Sterile, Single-Use IO Tray Cleared by the U.S. Food and Drug AdministrationWAYNE, Pa., May 09, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a global leader in medical technologies and pioneer in intraosseous vascular access, today announced the launch of the Arrow™ EZ-IO™ Intraosseous Access Procedure Tray. This sterile, single-use tray includes all the components required for the IO access procedure, enabling a streamlined clinician workflow. The new Arrow™ EZ
- GlobeNewswire
Outcomes From Two New Head-to-Head Randomized Controlled Trials Involving the UroLift™ System Highlight a Superior Patient Experience* Against Rezūm and Its Advantage Over Medical Therapy as an Early Intervention for BPH
WAYNE, Pa., May 07, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a global leader in medical technologies, today announced the presentation of new research findings from the 2024 American Urological Association Annual Meeting in San Antonio, TX, May 3 – 6, 2024, showcasing excellent patient experience* with the Prostatic Urethral Lift (PUL) with the UroLift™ System for benign prostatic hyperplasia (BPH). This year’s research marks the first time results from two randomized head-to-
ZacksUnlocking Teleflex (TFX) International Revenues: Trends, Surprises, and Prospects
Evaluate Teleflex's (TFX) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.
